Acurx Pharmaceuticals, LLC

  • Home
  • About
    • Management / Consultants
    • Scientific Advisors
    • Board of Directors
  • Pipeline
    • Overview
    • Ibezapolstat
    • ACX-375C
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Videos
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Videos

FDA Grants QIDP Designation to Acurx’s Lead Antibiotic Product Candidate, ACX-362E for Clostridium Difficile Infection

Jun 20, 2018
    • 1
    • 2
    © 2021 Acurx Pharmaceuticals, LLC. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap